US Patent Application No: 2010/0047,262

Number of patents in Portfolio can not be more than 2000

NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are novel methods and compositions for combating diseases characterized by deposition of amyloid. The methods generally rely on immunization against amyloid precursor protein (APP) or beta amyloid (Aβ). Immunization is preferably effected by administration of analogues of autologous APP or Aβ, said analogues being capable of inducing antibody production against the autologous amyloidogenic polypeptides. Especially preferred as an immunogen is autologous Aβ which has been modified by introduction of one single or a few foreign, immunodominant and promiscuous T-cell epitopes. Such methods and means include methods for the preparation of analogues and pharmaceutical formulations, as well as nucleic acid fragments, vectors, transformed cells, polypeptides and pharmaceutical formulations.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
H. LUNDBECK A/SVALBY-COPENHAGEN195

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Degan, Florence Dal Horsholm, DK 4 30
Jensen, Martin Roland Horsholm, DK 12 92
Koefoed, Peter Horsholm, DK 5 61
Nielsen, Klaus Gregorius Horsholm, DK 16 179
Rasmussen, Peter Birk Horsholm, DK 25 167

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (2)
* 5,192,688 Histological analysis method 10 1991
* 2004/0062,802 Maximizing effectiveness of substances used to improve health and well being 41 2003
 
BAVARIAN NORDIC, INC. (1)
* 2002/0090,379 INDUCING ANTIBODY RESPONSE AGAINST SELF-PROTEINS WITH THE AID OF FOREIGN T-CELL EPITOPES 14 1997
 
CORTECH, INC. (1)
* 5,573,916 Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier 14 1994
 
GLAXOSMITHKLINE LLC (1)
* 5,854,204 A.beta. peptides that modulate .beta.-amyloid aggregation 109 1996
 
EPIMMUNE INC. (1)
* 5,736,142 Alteration of immune response using pan DR-binding peptides 81 1994
 
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT (1)
* 4,601,903 Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease 79 1985
 
The Scripps Research Institute (4)
* 4,599,230 Synthetic hepatitis B virus vaccine including both T cell and B cell determinants 110 1984
* 4,599,231 Synthetic hepatitis B virus vaccine including both T cell and B cell determinants 98 1984
* 5,709,995 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses 22 1994
* 5,780,036 Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus 14 1995
 
PHARMEXA A/S (4)
* 6,645,500 Method for down-regulating osteoprotegerin ligand activity 15 1999
* 2003/0185,845 Novel immunogenic mimetics of multimer proteins 2 2002
* 2005/0163,744 Novel method for down-regulation of amyloid 9 2004
* 2005/0180,947 Novel application of vaccination against TNF-alpha 1 2004
 
HUNTINGTON POTTER (1)
* 5,780,587 Compounds and methods for inhibiting .beta.-protein filament formation and neurotoxicity 79 1995
 
SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (1)
* 4,608,251 LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues 81 1984
 
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (1)
* 5,278,056 Retroviral packaging cell lines and process of using same 43 1992
 
Bavarian Nordic A/S (1)
* 2004/0141,958 Novel methods for therapeutic vaccination 26 2003
 
ALCON RESEARCH, LTD. (1)
* 5,874,469 Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs 5 1996
 
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (1)
* 5,747,323 Retroviral vectors comprising a VL30-derived psi region 3 1994
 
H. LUNDBECK A/S (5)
* 7,135,181 Method for down-regulation of amyloid 15 2001
* 2002/0187,157 Novel method for down-regulation of amyloid 12 2001
* 2003/0086,938 Novel methods for down-regulation of amyloid 27 2002
* 2003/0157,117 Novel method for down-regulation of amyloid 21 2002
* 2009/0092,579 NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID 1 2008
 
NEW YORK UNIVERSITY (2)
* 2002/0077,288 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits 9 2001
* 6,713,450 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid .beta. for induction of an immune response to amyloid .beta. and amyloid deposits 46 2001
 
SCIOS NOVA INC. (CHANGED TO) (1)
* 5,223,482 Recombinant Alzheimer's protease inhibitory amyloid protein and method of use 31 1989
 
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (1)
* 4,596,792 Safe vaccine for hepatitis containing polymerized serum albumin 60 1984
 
Milkhaus Laboratory, Inc. (1)
* 5,851,996 Materials and methods for treatment of plaquing diseases 93 1998
 
BEALE STREET 143 INVEST APS (1)
* 7,097,837 Synthetic vaccine agents 16 2002
 
JANSSEN ALZHEIMER IMMUNOTHERAPY (6)
* 6,787,523 Prevention and treatment of amyloidogenic disease 75 1998
* 6,761,888 Passive immunization treatment of Alzheimer's disease 90 2000
* 6,787,144 Prevention and treatment of amyloidogenic disease 64 2000
* 6,875,434 Methods of treatment of Alzheimer's disease 64 2000
* 6,787,637 N-Terminal amyloid-.beta. antibodies 77 2000
* 6,946,135 Prevention and treatment of amyloidogenic disease 42 2004
 
UNIVERSITY OF WASHINGTON (1)
* 6,340,783 Rodent models of human amyloidoses 29 1996
 
Musashi Engineering Kabushiki Kaisha (1)
* 4,578,770 Method of discriminating sheet 50 1983
 
INTELLECT NEUROSCIENCES INC. (1)
* 2004/0091,945 Peptides and methods of screening immunogenic peptide vaccines against Alzheimer's Disease 9 2003
 
TRUSTEES OF BOSTON UNIVERSITY (1)
* 5,200,339 Proteases causing abnormal degradation of amyloid .beta.-protein precursor 41 1991
 
United Biomedical, Inc. (1)
* 2003/0068,325 Immunogenic peptide composition for the prevention and treatment of Altzheimers Disease 11 2001
 
GLAXOSMITHKLINE BIOLOGICALS SA (1)
* 6,544,518 Vaccines 47 2000
 
Pharnexa A/S (1)
* 2007/0041,945 NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID 3 2006
 
RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (1)
* 5,589,154 Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease 78 1994
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

  • No Forward Cites to Display